|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Transferase
|
 |
|
Title:
|
 |
Crystal structure of the activin/actriib extracellular domai
|
|
Structure:
|
 |
Activin receptor type iib precursor. Chain: a, c. Fragment: extracellular domain. Synonym: actr-iib. Engineered: yes. Inhibin beta a chain. Chain: b, d. Synonym: activin beta-a chain, erythroid differentiation pr edf.
|
|
Source:
|
 |
Mus musculus. House mouse. Organism_taxid: 10090. Gene: acvr2b. Expressed in: escherichia coli. Expression_system_taxid: 562. Homo sapiens. Human. Organism_taxid: 9606.
|
|
Biol. unit:
|
 |
Tetramer (from
)
|
|
Resolution:
|
 |
|
2.30Å
|
R-factor:
|
0.210
|
R-free:
|
0.286
|
|
|
Authors:
|
 |
J.Greenwald,M.E.Vega,G.P.Allendorph,W.H.Fischer,W.Vale,S.Cho Center For Structural Genomics (Jcsg)
|
Key ref:
|
 |
J.Greenwald
et al.
(2004).
A flexible activin explains the membrane-dependent cooperative assembly of TGF-beta family receptors.
Mol Cell,
15,
485-489.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
19-Jan-04
|
Release date:
|
10-Aug-04
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
|
|
|
P27040
(AVR2B_MOUSE) -
Activin receptor type-2B
|
|
|
|
Seq: Struc:
|
 |
 |
 |
536 a.a.
91 a.a.
|
|
|
|
|
|
|
 |
 |
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
Chains A, C:
E.C.2.7.11.30
- Receptor protein serine/threonine kinase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
ATP + [receptor-protein] = ADP + [receptor-protein] phosphate
|
 |
 |
 |
 |
 |
ATP
|
+
|
[receptor-protein]
|
=
|
ADP
|
+
|
[receptor-protein] phosphate
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
extracellular region
|
2 terms
|
 |
|
Biological process
|
transmembrane receptor protein serine/threonine kinase signaling pathway
|
1 term
|
 |
|
Biochemical function
|
growth factor activity
|
5 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Mol Cell
15:485-489
(2004)
|
|
PubMed id:
|
|
|
|
|
| |
|
A flexible activin explains the membrane-dependent cooperative assembly of TGF-beta family receptors.
|
|
J.Greenwald,
M.E.Vega,
G.P.Allendorph,
W.H.Fischer,
W.Vale,
S.Choe.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
A new crystal structure of activin in complex with the extracellular domain of
its type II receptor (ActRIIb-ECD) shows that the ligand exhibits an unexpected
flexibility. The motion in the activin dimer disrupts its type I receptor
interface, which may account for the disparity in its affinity for type I versus
type II receptors. We have measured the affinities of activin and its antagonist
inhibin for ActRIIb-ECD and found that the affinity of the 2-fold symmetric
homodimer activin for ActRIIb-ECD depends on the availability of two spatially
coupled ActRIIb-ECD molecules, whereas the affinity of the heterodimer inhibin
does not. Our results indicate that activin's affinity for its two receptor
types is greatly influenced by their membrane-restricted setting. We propose
that activin affinity is modulated by the ligand flexibility and that
cooperativity is achieved by binding to two ActRII chains that immobilize
activin in a type I binding-competent orientation.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Figure 1. Ligand Flexibility for Receptor Assembly in the
Membrane
|
 |
Figure 3.
Figure 3. The 1:1 Stoichiometry of the Complex Formed
between Inhibin and ActRIIb-ECD
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Cell Press:
Mol Cell
(2004,
15,
485-489)
copyright 2004.
|
|
| |
Figures were
selected
by the author.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
L.Calvanese,
D.Marasco,
N.Doti,
A.Saporito,
G.D'Auria,
L.Paolillo,
M.Ruvo,
and
L.Falcigno
(2010).
Structural investigations on the Nodal-Cripto binding: a theoretical and experimental approach.
|
| |
Biopolymers, 93,
1011-1021.
|
 |
|
|
|
|
 |
C.Belville,
J.D.Maréchal,
S.Pennetier,
P.Carmillo,
L.Masgrau,
L.Messika-Zeitoun,
J.Galey,
G.Machado,
D.Treton,
J.Gonzalès,
J.Y.Picard,
N.Josso,
R.L.Cate,
and
N.di Clemente
(2009).
Natural mutations of the anti-Mullerian hormone type II receptor found in persistent Mullerian duct syndrome affect ligand binding, signal transduction and cellular transport.
|
| |
Hum Mol Genet, 18,
3002-3013.
|
 |
|
|
|
|
 |
J.N.Cash,
C.A.Rejon,
A.C.McPherron,
D.J.Bernard,
and
T.B.Thompson
(2009).
The structure of myostatin:follistatin 288: insights into receptor utilization and heparin binding.
|
| |
EMBO J, 28,
2662-2676.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.Nickel,
W.Sebald,
J.C.Groppe,
and
T.D.Mueller
(2009).
Intricacies of BMP receptor assembly.
|
| |
Cytokine Growth Factor Rev, 20,
367-377.
|
 |
|
|
|
|
 |
K.Heinecke,
A.Seher,
W.Schmitz,
T.D.Mueller,
W.Sebald,
and
J.Nickel
(2009).
Receptor oligomerization and beyond: a case study in bone morphogenetic proteins.
|
| |
BMC Biol, 7,
59.
|
 |
|
|
|
|
 |
Y.Xia,
and
A.L.Schneyer
(2009).
The biology of activin: recent advances in structure, regulation and function.
|
| |
J Endocrinol, 202,
1.
|
 |
|
|
|
|
 |
A.Galat,
G.Gross,
P.Drevet,
A.Sato,
and
A.Ménez
(2008).
Conserved structural determinants in three-fingered protein domains.
|
| |
FEBS J, 275,
3207-3225.
|
 |
|
|
|
|
 |
J.A.Kelber,
G.Shani,
E.C.Booker,
W.W.Vale,
and
P.C.Gray
(2008).
Cripto is a noncompetitive activin antagonist that forms analogous signaling complexes with activin and nodal.
|
| |
J Biol Chem, 283,
4490-4500.
|
 |
|
|
|
|
 |
R.Stamler,
H.T.Keutmann,
Y.Sidis,
C.Kattamuri,
A.Schneyer,
and
T.B.Thompson
(2008).
The Structure of FSTL3{middle dot}Activin A Complex: DIFFERENTIAL BINDING OF N-TERMINAL DOMAINS INFLUENCES FOLLISTATIN-TYPE ANTAGONIST SPECIFICITY.
|
| |
J Biol Chem, 283,
32831-32838.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
R.V.Korupolu,
U.Muenster,
J.D.Read,
W.Vale,
and
W.H.Fischer
(2008).
Activin A/bone morphogenetic protein (BMP) chimeras exhibit BMP-like activity and antagonize activin and myostatin.
|
| |
J Biol Chem, 283,
3782-3790.
|
 |
|
|
|
|
 |
Y.Makanji,
K.L.Walton,
M.C.Wilce,
K.L.Chan,
D.M.Robertson,
and
C.A.Harrison
(2008).
Suppression of inhibin A biological activity by alterations in the binding site for betaglycan.
|
| |
J Biol Chem, 283,
16743-16751.
|
 |
|
|
|
|
 |
D.Weber,
A.Kotzsch,
J.Nickel,
S.Harth,
A.Seher,
U.Mueller,
W.Sebald,
and
T.D.Mueller
(2007).
A silent H-bond can be mutationally activated for high-affinity interaction of BMP-2 and activin type IIB receptor.
|
| |
BMC Struct Biol, 7,
6.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
S.Han,
P.Loulakis,
M.Griffor,
and
Z.Xie
(2007).
Crystal structure of activin receptor type IIB kinase domain from human at 2.0 Angstrom resolution.
|
| |
Protein Sci, 16,
2272-2277.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
S.Yuzawa,
Y.Opatowsky,
Z.Zhang,
V.Mandiyan,
I.Lax,
and
J.Schlessinger
(2007).
Structural basis for activation of the receptor tyrosine kinase KIT by stem cell factor.
|
| |
Cell, 130,
323-334.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
T.F.Lerch,
M.Xu,
T.S.Jardetzky,
K.E.Mayo,
I.Radhakrishnan,
R.Kazer,
L.D.Shea,
and
T.K.Woodruff
(2007).
The structures that underlie normal reproductive function.
|
| |
Mol Cell Endocrinol, 267,
1-5.
|
 |
|
|
|
|
 |
T.F.Lerch,
S.Shimasaki,
T.K.Woodruff,
and
T.S.Jardetzky
(2007).
Structural and biophysical coupling of heparin and activin binding to follistatin isoform functions.
|
| |
J Biol Chem, 282,
15930-15939.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.E.Harrington,
S.A.Morris-Triggs,
B.T.Ruotolo,
C.V.Robinson,
S.Ohnuma,
and
M.Hyvönen
(2006).
Structural basis for the inhibition of activin signalling by follistatin.
|
| |
EMBO J, 25,
1035-1045.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
G.P.Allendorph,
W.W.Vale,
and
S.Choe
(2006).
Structure of the ternary signaling complex of a TGF-beta superfamily member.
|
| |
Proc Natl Acad Sci U S A, 103,
7643-7648.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
X.Wang,
R.H.Baloh,
J.Milbrandt,
and
K.C.Garcia
(2006).
Structure of artemin complexed with its receptor GFRalpha3: convergent recognition of glial cell line-derived neurotrophic factors.
|
| |
Structure, 14,
1083-1092.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
M.A.Brown,
Q.Zhao,
K.A.Baker,
C.Naik,
C.Chen,
L.Pukac,
M.Singh,
T.Tsareva,
Y.Parice,
A.Mahoney,
V.Roschke,
I.Sanyal,
and
S.Choe
(2005).
Crystal structure of BMP-9 and functional interactions with pro-region and receptors.
|
| |
J Biol Chem, 280,
25111-25118.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
R.L.Rich,
and
D.G.Myszka
(2005).
Survey of the year 2004 commercial optical biosensor literature.
|
| |
J Mol Recognit, 18,
431-478.
|
 |
|
|
|
|
 |
R.W.Cook,
T.B.Thompson,
S.P.Kurup,
T.S.Jardetzky,
and
T.K.Woodruff
(2005).
Structural basis for a functional antagonist in the transforming growth factor beta superfamily.
|
| |
J Biol Chem, 280,
40177-40186.
|
 |
|
|
|
|
 |
U.Muenster,
C.A.Harrison,
C.Donaldson,
W.Vale,
and
W.H.Fischer
(2005).
An activin-A/C chimera exhibits activin and myostatin antagonistic properties.
|
| |
J Biol Chem, 280,
36626-36632.
|
 |
|
|
|
|
 |
X.H.Feng,
and
R.Derynck
(2005).
Specificity and versatility in tgf-beta signaling through Smads.
|
| |
Annu Rev Cell Dev Biol, 21,
659-693.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
| |